Zinc-induced self-association of complement C3b and Factor H: Implications for inflammation and age-related macular degeneration (English)
- New search for: Nan, R.
- New search for: Tetchner, S.
- New search for: Rodriguez, E.
- New search for: Pao, P. J.
- New search for: Gor, J.
- New search for: Lengyel, I.
- New search for: Perkins, S.
- New search for: Nan, R.
- New search for: Tetchner, S.
- New search for: Rodriguez, E.
- New search for: Pao, P. J.
- New search for: Gor, J.
- New search for: Lengyel, I.
- New search for: Perkins, S.
-
ISSN:
- Article (Journal) / Print
-
Title:Zinc-induced self-association of complement C3b and Factor H: Implications for inflammation and age-related macular degeneration
-
Contributors:Nan, R. ( author ) / Tetchner, S. ( author ) / Rodriguez, E. ( author ) / Pao, P. J. ( author ) / Gor, J. ( author ) / Lengyel, I. ( author ) / Perkins, S. ( author )
-
Published in:MOLECULAR IMMUNOLOGY ; 56, 3 ; 285
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam.
-
Publication date:2013-01-01
-
Size:285 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 571.96
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 571.96 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 56, Issue 3
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 141
-
Program of the 14th European Meeting on Complement and Human Diseases| 2013
- 151
-
14th European Meeting on Complement in Human Disease, Jena, Germany, August 17–21, 2013Zipfel, Peter F. / Skerka, Christine / Hallström, Teresia / Wolf, Gunter et al. | 2013
- 152
-
Human complement control and complement evasion by pathogenic microbes – Tipping the balanceZipfel, Peter F. / Hallström, Teresia / Riesbeck, Kristian et al. | 2013
- 161
-
Complement and innate immune evasion strategies of the human pathogenic fungus Candida albicansLuo, S. / Skerka, C. / Kurzai, O. / Zipfel, P. F. et al. | 2013
- 170
-
Complement factor H related proteins (CFHRs)Skerka, C. / Chen, Q. / Fremeaux-Bacchi, V. / Roumenina, L. T. et al. | 2013
- 181
-
Novel roles for complement receptors in T cell regulation and beyondKemper, Claudia / Köhl, Jörg et al. | 2013
- 191
-
Properdin in complement activation and tissue injuryLesher, Allison M. / Nilsson, Bo / Song, Wen-Chao et al. | 2013
- 199
-
Complement therapy in atypical haemolytic uraemic syndrome (aHUS)Wong, E. K. S. / Goodship, T. H. J. / Kavanagh, D. et al. | 2013
- 213
-
Autoantibodies against complement components and functional consequencesDragon-Durey, M. A. / Blanc, C. / Marinozzi, M. C. / van Schaarenburg, R. A. / Trouw, L. A. et al. | 2013
- 222
-
Toward a structure-based comprehension of the lectin pathway of complementKjaer, Troels R. / Thiel, Steffen / Andersen, Gregers R. et al. | 2013
- 232
-
An international serum standard for application in assays to detect human complement activation productsBergseth, Grethe / Ludviksen, Judith K. / Kirschfink, Michael / Giclas, Patricia C. / Nilsson, Bo / Mollnes, Tom E. et al. | 2013
- 240
-
Soluble collectin-12 (CL-P1) triggers activation of the alternative complement pathwayMa, Y.J. / Skjoedt, M.-O. / Garred, P. et al. | 2013
- 240
-
IgG hexamerization mediates efficient C1q docking and complement-dependent cytotoxicity (CDC)Beurskens, F. / de Jong, R. / Voorhorst, M. / Strumane, K. / Lindorfer, M.A. / Taylor, R.P. / Ollmann-Saphire, E. / Burton, D. / Schuurman, J. / Parren, P.W.H. et al. | 2013
- 241
-
C5aR expression in a floxed C5aR GFP reporter gene knockin mouseKarsten, C. / Broker, K. / Westendorf, F. / Laumonnier, Y. / Kohl, G. / Kohl, J. et al. | 2013
- 241
-
Assembly and stability of C3 proconvertase and C3 convertase: Effect of CFH and C3NeFBettoni, S. / Donadelli, R. / Ngo, S. / Fremeaux-Bacchi, V. / Noris, M. et al. | 2013
- 242
-
Glycerol-3-phosphate dehydrogenase 2 is a novel Candida albicans complement inhibitorLuo, S. / Reza, M. / Hoffmann, R. / Skerka, C. / Verschoor, A. / Zipfel, P.F. et al. | 2013
- 242
-
A novel C3 fragment found in normal plasma and serum: Its implications for C3 tickoverBuchberger, A. / Seilly, D. / Lachmann, P. et al. | 2013
- 242
-
MAP-1, MASP-1 and MASP-3 form heterocomplexes with each otherRosbjerg, A. / Munthe-Fog, L. / Garred, P. / Skjoedt, M. O. et al. | 2013
- 243
-
The impact of complement evasion on transmission of malariaPradel, G. / Simon, N. / Lasonder, E. / Scheuermayer, M. / Kuhn, A. / Fischer, R. / Zipfel, P. / Skerka, C. et al. | 2013
- 243
-
CspA from Borrelia burgdorferi inhibits the terminal complement pathwayHallstrom, T. / Siegel, C. / Morgelin, M. / Kraiczy, P. / Skerka, C. / Zipfel, P. F. et al. | 2013
- 243
-
Streptococcus pneumoniae: Endopeptidase O (PepO): A novel C1q binding complement inhibitorAgarwal, V. / Riesbeck, K. / Fulde, M. / Bergmann, S. / Blom, A. et al. | 2013
- 244
-
C5a synergizes with IL10 and Toll-like receptors to control the peritoneal B1 cell compartmentBröker, K. / Figge, J. / Karsten, C.M. / Köhl, J. et al. | 2013
- 244
-
The use of a rapid fluorogenic neuraminidase assay to differentiate Streptococcus pneumoniae-associated haemolytic uremic syndrome (HUS) from other forms of HUSSzilágyi, Î. / Kiss, N. / Kelen, K. / Reusz, G. / Szabó, A.J. / Prohászka, Z. et al. | 2013
- 244
-
Regulatory role of C5a in human PMN activity during whole blood infection with Candida albicansHünniger, K. / Bieber, K. / Kurzai, O. et al. | 2013
- 245
-
Th1 induction requires T cell-derived complement C3a and CD46 activationGhannam, A. / Kemper, C. / Drouet, C. et al. | 2013
- 245
-
Neutrophil components as regulators of the complement systemO'Flynn, J. / Dixon, K. / Krol, M. C. F. / Daha, M. R. / van Kooten, C. et al. | 2013
- 246
-
Cholesterol crystals activate the complement system and are phagocytosed in a complement-dependent mannerNymo, S. / Samstad, E.O. / Niyonzima, N. / Aune, M.H. / Bergseth, G. / Ryan, L. / Brekke, O.-L. / Latz, E. / Lambris, J.D. / Espevik, T. et al. | 2013
- 246
-
Combined inhibition of C5 and CD14 attenuates organ inflammation in porcine Escherichia coli sepsisEgge, K.H. / Thorgersen, E.B. / Lindstad, J.K. / Pharo, A.M. / Bongoni, A.K. / Rieben, R. / Barratt-Due, A. / Mollnes, T.E. et al. | 2013
- 247
-
A functional variant in the CFI gene confers a high risk of age-related macular degenerationvan de Ven, J.P.H. / Nilsson, S.C. / Tan, P.L. / Buitendijk, G. / Ristau, T. / Mohlin, F.C. / Nabuurs, S.B. / Schoenmaker-Koller, F.E. / Smailhodzic, D. / Campochiarro, P.A. et al. | 2013
- 247
-
Circulating C5a receptor (cC5aR) as a novel biomarker of septic shock in humansDenk, S. / Rittirsch, D. / Barth, H. / Sarma, J. / Ward, P. / Huber-Lang, M. et al. | 2013
- 248
-
Blocking C5aR with C5aR antagonist protects mice from uropathogenic Escherichia coli-induced kidney infectionCai, G. D. / Wang, N. / Zhang, T. / Wei, Y. / Li, Z. F. / Zhou, W. / Li, K. et al. | 2013
- 248
-
A prevalent CFHR1/FH reverse hybrid gene in aHUS patients induces deregulation of the alternative pathwayRoumenina, L. / Strain, L. / Deury, D. / Merle, N. / Halbwachs-Mecarelli, L. / Goodship, T. / Fremeaux-Bacchi, V. et al. | 2013
- 248
-
Complement deregulation in dense deposit disease by a novel CFHR2-CFHR5 hybrid proteinChen, Q. / Wiesener, M. / Eberhardt, H. U. / Hartmann, A. / Kirschfink, M. / Amann, K. / Buettner, M. / Goodship, T. / Hugo, C. / Skerka, C. et al. | 2013
- 249
-
Differentiating Dense Deposit Disease and C3 Glomerulonephritis by biomarker profilingSmith, R. / Zhang, Y. / Martin, B. / Meyer, N. / Shao, D.W. / Xaio, X. / Nester, C. et al. | 2013
- 249
-
Screening of genes encoding complement (regulatory) proteins in patients with C3 glomerulopathyWestra, D. / van den Heuvel, L. P. / van Wijk, J. A. E. / Wetzels, J. F. M. / van de Kar, N. C. A. et al. | 2013
- 250
-
Key role of tissue factor in complement-mediated coagulation activation by Escherichia coli and LPSBrekke, O.-L. / Landsem, A. / Fure, H. / Christiansen, D. / Waage-Nielsen, E. / Lambris, J.D. / Mollnes, T.E. et al. | 2013
- 250
-
Shiga toxin 2 binds and modulates complement regulatory proteins in the fluid phase and on host cell membranesOrth-Holler, D. / Ehrlenbach, S. / Rosales, A. / Poolpol, K. / Zipfel, P. F. / Skerka, C. / Cordoba, S. R. D. / Karpman, D. / Karch, H. / Wurzner, R. et al. | 2013
- 251
-
Von Willebrand factor binds to surface-bound C1q in vitroKölm, R. / Schaller, M. / Vanhecke, D. / Hovinga, J.A. Kremer / Khanicheh, E. / Kaufmann, B.A. / Trendelenburg, M. et al. | 2013
- 251
-
Von Willebrand Factor interacts with Factor H and enhances its cofactor activityRayes, J. / Roumenina, L. / Repressé, Y. / Dimitrov, J. / Ing, M. / Delignat, S. / Halbwachs-Mecarelli, L. / Borel-Derlon, A. / Kaveri, S. / Frémaux-Bacchi, V. et al. | 2013
- 251
-
Red blood cell-derived microvesicles amplify systemic inflammation in endotoxemic mice by thrombin-dependent activation of complementZecher, D. / Cumpelik, A. / Schifferli, J. et al. | 2013
- 252
-
Enhanced complement activation by low-avidity anti-citrullinated protein antibodies (ACPA) possibly explains the association with enhanced joint destruction in rheumatoid arthritisBouwens, T. / Suwannalai, P. / Scherer, U. / van der Helm-van Mil, A. / van Schaardenburg, D. / Huizinga, T. / Toes, R. / Trouw, L. et al. | 2013
- 252
-
Treatment with eculizumab of patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) associated with CD59 deficiencyMevorach, D. et al. | 2013
- 252
-
Plasma concentrations of C3 and C4 are linked to cardiovascular risk factors and to the metabolic syndromeNilsson, B. / Ekdahl, K. N. / Lind, L. et al. | 2013
- 253
-
Functional analysis of a complement polymorphism (rs17611) associated with Rheumatoid ArthritisGiles, J. / Morgan, B. P. / Harris, C. L. et al. | 2013
- 253
-
C3 dysregulation due to factor H deficiency is MASP-1/3 independent in vivoRuseva, M. M. / Takahashi, M. / Fujita, T. / Pickering, M. C. et al. | 2013
- 253
-
C5a induces recruitment of STRO-1 pulp progenitor cells: Possible role in the regenerative process after dentin/pulp injuryChmilewsky, F. / Jeanneau, C. / Laurent, P. / Kirschfink, M. / About, I. et al. | 2013
- 254
-
Genetic analysis of the complement and coagulation pathways in atypical Hemolytic Uremic SyndromeSmith, R. / Bu, F. / Mega, T. / Meyer, N. / Wang, K. / Thomas, C. / Nester, C. et al. | 2013
- 254
-
Mechanism of neutrophil dysfunction: Neutrophil serine proteases cleave and inactivate the C5a receptorvan den Berg, C. / Tambourgi, D. / Clark, H. / Hoong, J. / Spiller, B. / McGreal, E. et al. | 2013
- 254
-
Complement receptor type 2 is crucial in mediating neuroinflammation and neuropathology after experimental closed head injury in miceNeher, M. / Keene, C. / Rich, M. / Weckbach, S. / Bolden, A. / Losacco, J. / Holers, V. M. / Stahel, P. et al. | 2013
- 255
-
High density CGH array for the identification and characterization of genomic rearrangements in the RCA gene clusterGarcia-Fernandez, J. M. / Pinto, S. / de Cordoba, S. R. et al. | 2013
- 255
-
Prevalence of C3 mutations in primary membranoproliferative glomerulonephritisValoti, E. / Bresin, E. / Piras, R. / Alberti, M. / Sorosina, A. / Donadelli, R. / Remuzzi, G. / Noris, M. et al. | 2013
- 256
-
Identification of novel intracellular differential spliced variants of MASP1Munthe-Fog, L. / Schjerling, P. / Skjoedt, M. O. / Krag, T. / Madsen, H. O. / Vissing, J. / Lauersen, H. / Kjaer, M. / Garred, P. et al. | 2013
- 256
-
Mannose binding lectin is associated with injured vessels in clinical and experimental traumatic brain injury and its deletion is protectiveOrsini, F. / Longhi, L. / De Blasio, D. / Parrella, S. / Zangari, R. / Ortolano, F. / Stocchetti, N. / De Simoni, M. G. et al. | 2013
- 257
-
Evidence for intracellular complement activation vital to Th1 immunityLiszewski, M. K. / Kolev, M. / Le Friec, G. / Leung, M. / Bertram, P. M. / Pickering, M. C. / Drouet, C. / Meri, S. / Arstila, T. P. / Pekkarinen, P. T. et al. | 2013
- 257
-
Eculizumab drug monitoring in serum and urine opens new insights into therapy of complement-mediated nephropathiesWehling, C. / Amon, O. / Hoehenstein, B. / Pape, L. / Bommer, M. / Kirschfink, M. et al. | 2013
- 257
-
Transient therapeutic inhibition of MASP-2 dependent lectin pathway functional activity provides a significant degree of protection from ischaemia/reperfusion injury in models of myocardial infarction and strokeChrysanthou, E. / Clark, J. / Lynch, N. J. / Dudler, T. / Samani, N. J. / Marber, M. / Demopulos, G. / Schwaeble, W. J. et al. | 2013
- 258
-
C5L2-mediated signals control contraction of human Th1 responsesFara, A. / Sumner, J. / Kolev, M. / Roberts, C. / Lappegård, K.T. / Garred, P. / Arno, M. / Lavender, P. / Lambris, J.D. / Mollnes, T.E. et al. | 2013
- 259
-
P-I Snake Venom Metalloproteinase is able to activate the complement system by direct cleavage of the cascade central componentsPidde-Queiroz, G. / Magnoli, F. C. / Portaro, F. C. V. / Serrano, S. M. T. / van den Berg, C. W. / Tambourgi, D. V. et al. | 2013
- 259
-
Envenomation by African adders (Bitis ssp.) induces complement activationPaixão-Cavalcante, D. / da SIlva, W. Dias / Tambourgi, D. Vilarinho et al. | 2013
- 259
-
The innate pathogen recognition molecule ficolin-1 exhibit differential binding to leukocyte subsets, providing a novel link between innate and adaptive immunityGenster, N. / Ma, Y.J. / Munthe-Fog, L. / Garred, P. et al. | 2013
- 260
-
Cholesterol crystals induce inflammasome activation and cytokine release in a complement-dependent mannerSamstad, E. / Niyonzima, N. / Nymo, S. / Aune, M. / Ryan, L. / Brekke, O. L. / Sandanger, I. / Aukrust, P. / Damas, J. K. / Latz, E. et al. | 2013
- 260
-
Potential roles for local adipocytes and fibroblasts in activation of the alternative pathway of complement in inflammatory arthritis in miceArend, W.P. / Mehta, G. / Antonioli, A.H. / Takahashi, M. / Takahashi, K. / Stahl, G.L. / Holers, V.M. / Banda, N.K. et al. | 2013
- 261
-
Structural insight on the recognition of complement activator bound opsonins by complement receptor 3Bajic, G. / Yatime, L. / Vorup-Jensen, T. / Andersen, G. R. et al. | 2013
- 261
-
Electron microscopy of properdin in complex with C3bBb convertaseAlcorlo, M. / de Cordoba, S. R. / Llorca, O. et al. | 2013
- 261
-
Structure of C1-antibody complexes determined by cryo-electron tomographyDiebolder, C.A. / Koning, R.I. / Koster, A.J. / Gros, P. et al. | 2013
- 262
-
Plasma-derived MBL shows direct interaction with C1-inhibitorKeizer, M. / Brouwer, N. / Kamp, A. / van de Wetering, M. / Wouters, D. / Kuijpers, T. et al. | 2013
- 262
-
Further insights into modulation of complement activation by the factor H-related family of proteinsCaesar, J. / de Jorge, E. G. / Chittock, E. / Malik, T. / Ward, P. / Pickering, M. / Lea, S. et al. | 2013
- 263
-
Regulation of complement-dependent cytotoxicity by microRNAHillman, Y. / Shomron, N. / Fishelson, Z. et al. | 2013
- 263
-
Dendritic cells express alternative pathway components properdin and factor H: Differential regulation by Interferons and IL-27O'Flynn, J. / Dixon, K. / Klar Mohamad, N. / Daha, M. R. / van Kooten, C. et al. | 2013
- 263
-
Optimisation and evaluation of the next generation of triple-targeted immune inhibitors from the ''mini-FH class'' of engineered complement inhibitorsSchmidt, C. / Lin, Z. / Risitano, A. / DeAngelis, R. / Simmet, T. / Ricklin, D. / Lambris, J. et al. | 2013
- 264
-
Novel monoclonal antibodies to C3d for non-invasively monitoring the activity of complement in glomerular and retinal diseaseRohrer, B. / Kulik, L. / Mitchell, L.M. / Hourcade, D.E. / Hannan, J.P. / Coughlin, B. / Woodell, A.S. / Pickering, M.C. / Holers, V.M. / Thurman, J.M. et al. | 2013
- 264
-
Phase 1 clinical trial of novel complement C5 inhibitor coversinWeston-Davies, W. / Westwood, J. P. / Nunn, M. et al. | 2013
- 265
-
Complement involvement in periodontitis: Mechanisms and therapeutic interventionHajishengallis, G. / Maekawa, T. / Abe, T. / Hajishengallis, E. / Reis, E. / DeAngelis, R. / Lambris, J. et al. | 2013
- 265
-
Preclinical development and evaluation of compstatin analogs as an efficient and cost-effective treatment option for paroxysmal nocturnal hemoglobinuriaRicklin, D. / Reis, E. / Ricci, P. / Huang, Y. / Lin, Z. / Chen, H. / Resuello, R. / DeAngelis, R. / Risitano, A. / Lambris, J. et al. | 2013
- 265
-
Human FHΔ6–17 (a mini-FH) restores serum C3 levels in FH−/− miceHunze, E.-M. / Barbour, T. / Sheerin, N. / Pickering, M.C. / Marchbank, K. et al. | 2013
- 265
-
Human FH@D6-17 (a mini-FH) restores serum C3 levels in FH^-^/^- miceHunze, E. M. / Barbour, T. / Sheerin, N. / Pickering, M. C. / Marchbank, K. et al. | 2013
- 266
-
Thrombelastographic studies reveal a new mechanism in MASP-1-induced fibrin clottingJenny, L. / Dobó, J. / Gál, P. / Schroeder, V. et al. | 2013
- 266
-
Complement- and platelet-mediated shuttling of blood-borne bacteria to CD8a+ dendritic cellsBroadley, S. / Plaumann, A. / Seidlmeier, A. / Wanisch, A. / Luo, S. / Raemer, P. / Busch, D. / Verschoor, A. et al. | 2013
- 266
-
The novel complement inhibitor CMSD1 protein promotes Factor I-mediated degradation of C4b and C3b and inhibits MAC assembly and C9 polymerisationEscudero-Esparza, A. / Kalchishkova, N. / Kurbasic, E. / Jiang, W. G. / Blom, A. M. et al. | 2013
- 267
-
Expression and design of MAP1: CFH1–5 fusion protein, a dual inhibitor of complement activationNordmaj, M.A. / Hein, E. / Garred, P. / Munthe-Fog, L. et al. | 2013
- 267
-
Sushi Domain-Containing Protein 4 (SUSD4) inhibits complement by disrupting the formation of the classical C3 convertaseHolmquist, E. / Okroj, M. / Nodin, B. / Jirstrom, K. / Blom, A. et al. | 2013
- 267
-
Optimization of complement recruitment in EGFR-directed antibody therapyRosner, T. / Derer, S. / Klausz, K. / Dechant, M. / Lohse, S. / Berger, S. / Cossham, M. / Peipp, M. / Valerius, T. et al. | 2013
- 268
-
Β-O-N-Acetyl-d-glucosamine residue of wall teichoic acid of Staphylococcus aureus is required for serum antibody-mediated complement activationKurokawa, K. / Jun, D.J. / An, J.H. / Jeon, Y.-J. / Kim, N.-Y. / Xia, Q. / Peschel, A. / Lee, B.L. et al. | 2013
- 268
-
@b-O-N-Acetyl-d-glucosamine residue of wall teichoic acid of Staphylococcus aureus is required for serum antibody-mediated complement activationKurokawa, K. / Jun, D. J. / An, J. H. / Jeon, Y. J. / Kim, N. Y. / Xia, Q. / Peschel, A. / Lee, B. L. et al. | 2013
- 268
-
Activation of the complement system by the metalloproteinase Batroxase isolated from Bothrops atrox venomNogueira-Santos, C. / Pereira, J. C. / Casare-Ogasawara, T. / Cintra, A. / Sampaio, S. V. / Pereira-Crott, L. S. et al. | 2013
- 268
-
Dissociation and re-association properties of the dimerization domains of MASP-1 and MASP-2 indicate tight interaction but slow dimer formationDobó, J. / Paréj, K. / Donáth, N. / Závodszky, P. / Gál, P. et al. | 2013
- 269
-
Factor H interferes with C1q-A@b interaction, and dampens classical pathway activation and subsequent neuroinflammatory responseNayak, A. / Pednekar, L. / Waters, P. / Sim, R. B. / Kishore, U. et al. | 2013
- 269
-
Factor H interferes with C1q–Aβ interaction, and dampens classical pathway activation and subsequent neuroinflammatory responseNayak, A. / Pednekar, L. / Waters, P. / Sim, R.B. / Kishore, U. et al. | 2013
- 269
-
IgM-mediated activation of the lectin pathway of complement in pig-to-human xenotransplantation modelsBongoni, A. K. / Keirmeir, D. / Jenni, H. / Constantinescu, M. A. / Vogelin, E. / Rieben, R. et al. | 2013
- 269
-
Co-complexes of MASP-1 and MASP-2 drive lectin pathway activation in a manner inhibitable by MAp44Degn, S. / Jensen, L. / Jensenius, J. / Thiel, S. et al. | 2013
- 270
-
Measurement of soluble C5b-9 and pathway specific complement activation in a rat model of renal ischemia/reperfusion injuryKotimaa, J. / van der Pol, P. / Leijtens, S. / Klar-Mohamad, N. / Rutjes, H. / Daha, M. R. / van Kooten, C. et al. | 2013
- 270
-
Functional assessment of the three complement pathways of mouse complement system and quantification of mouse C3b/C3c/iC3b complex in circulationKotimaa, J. / O'flynn, J. / van Groningen, J. / Schilders, G. / Daha, M.R. / van Kooten, C. et al. | 2013
- 270
-
Collectin 11 – A new complement-associated pattern recognition moleculeHansen, S. et al. | 2013
- 271
-
Correlation of CR3 expression on neutrophils and monocytes with serum levels of ICAM-1 and fibrinogen in women using combined hormonal contraceptivesBertozi, R.I. / Stocco, B. / Franceschini, S.A. / Torqueti, M.R. / Machado, C.M. Marzocchi et al. | 2013
- 271
-
Effects of C1-inhibitor on clot development in human whole blood analyzed using rotational thromboelastographyLandsem, A. / Fure, H. / Waage-Nielsen, E. / Mollnes, T.E. / Brekke, O.-L. et al. | 2013
- 272
-
Complement activation associated with ADAMTS13 deficiency in human and murine thrombotic microangiopathyKarpman, D. / Tati, R. / Kristoffersson, A. C. / Stahl, A. L. / Rebetz, J. / Wang, L. / Licht, C. / Motto, D. et al. | 2013
- 272
-
Personalized therapy for colon cancerShah, K. et al. | 2013
- 272
-
Potential role of T cell microvesicles in mediating anti-thymocyte-globulin-induced hypercoagulobility in transplant patientsZecher, D. / Cumpelik, A. / Schifferli, J. et al. | 2013
- 273
-
Complement activation in thrombotic thrombocytopenic purpuraWestwood, J.-P. / Langley, K. / Heelas, E. / Machin, S. / Scully, M. et al. | 2013
- 273
-
Plasma levels of MASP-1 and MASP-2 are elevated in patients with type 1 diabetesFrauenknecht, V. / Ajjan, R. / Thiel, S. / Schroeder, V. et al. | 2013
- 274
-
Screening of autoantibodies against complement alternative pathway proteins in renal pathologiesNozal, P. / Garrido, S. / Sánchez-Corral, P. / de Córdoba, S. Rodríguez / López-Trascasa, M. et al. | 2013
- 274
-
Anti-C1q antibodies as a follow-up marker in SLE patientsBock, M. / Heijnen, I. / Trendelenburg, M. et al. | 2013
- 274
-
Low C4 gene copy numbers are associated with superior graft survival in patients transplanted with a deceased donor kidneyBay, J. T. / Schejbel, L. / Madsen, H. O. / Sorensen, S. / Hansen, J. M. / Garred, P. et al. | 2013
- 275
-
Role of ApoE and its isoforms in AMDVodisch, S. / Skerka, C. et al. | 2013
- 275
-
Soluble C5b-9, a marker for terminal complement activation, is not associated with markers of atherosclerosis or prevalent cardiovascular disease: The CODAM studyHertle, E. / van Greevenbroek, M.M. / Arts, I.C. / van der Kallen, C.J. / Ferreira, I. / Feskens, E.J. / Schalkwijk, C.G. / Stehouwer, C.D. et al. | 2013
- 276
-
Activation of the ficolin-lectin pathway during attacks of hereditary angioedemaCsuka, D. / Munthe-Fog, L. / Hein, E. / Zotter, Z. / Varga, L. / Prohaszka, Z. / Farkas, H. / Garred, P. et al. | 2013
- 276
-
Ficolin-3 mediated complement activation in patients with systemic lupus erythematosusHein, E. / Nielsen, C.T. / Munthe-Fog, L. / Jacobsen, S. / Garred, P. et al. | 2013
- 276
-
Ficolin-3 mediated lectin complement pathway activation is related to pathology and outcome in subarachnoid haemorrhage patientsZangari, R. / Munthe-Fog, L. / Zanier, E.R. / Hein, E. / Zoerle, T. / Orsini, F. / Parrella, S. / Conte, V. / Stocchetti, N. / Garred, P. et al. | 2013
- 277
-
Glial tumors and the complement cascadeBouwens, T. / Lamfers, M. / Veerhuis, R. / Dirven, C. / Trouw, L. / Al-Khawaja, H. et al. | 2013
- 277
-
Expression of membrane complement regulators in patients on peritoneal dialysis therapySei, Y. / Mizuno, M. / Imai, M. / Suzuki, Y. / Higashide, K. / Okada, N. / Harris, C. / Matsuo, S. / Ito, Y. et al. | 2013
- 278
-
Effect of anti-C1q antibodies from SLE patients on complement activationThanei, S. / Vanhecke, D. / Ploix, C. / Trendelenburg, M. et al. | 2013
- 278
-
Atypical haemolytic uraemic syndrome associated with a novel hybrid CFH/CFHR3 geneChallis, R. / Anderson, H. / Wong, E. / Reis, G. / Awan, A. / Waldron, M. / Strain, L. / Marchbank, K. / Goodship, T. / Kavanagh, D. et al. | 2013
- 278
-
Shiga toxin induces release of soluble ICAM-1 protein in primary human glomerular microvacular endothelial cellsVolokhina, E. / van der Velden, T. / Westra, D. / van de Kar, N. / van den Heuvel, L. et al. | 2013
- 279
-
Serum C3 levels are associated with the clinical manifestations and disease activity of microscopic polyangiitisLiu, D. / Chen, Y. / Min, X. / Wang, N. / Jia, Y. / Li, K. et al. | 2013
- 279
-
CD59 is a blood group antigenAnliker, M. / von Zabern, I. / Hochsmann, B. / Dohna-Schwake, C. / Kyrieleis, H. / Schrezenmeier, H. / Weinstock, C. et al. | 2013
- 280
-
Degradation of neutrophil extracellular traps, necrotic chromatin and DNA in patients with systemic lupus erythematosusLeffler, J. / Gullstrand, B. / Ciacma, K. / Jonsen, A. / Martin, M. / Bengtsson, A.A. / Blom, A.M. et al. | 2013
- 280
-
Age-related changes to glycosaminoglycans in human Bruch's membrane may contribute to immune dysregulation in AMDKeenan, T. / Clark, S. / Langford-Smith, A. / Pickford, C. / Holley, R. / Merry, C. / Day, A. / Bishop, P. et al. | 2013
- 280
-
Lectin pathway proteins in colorectal cancerStorm, L. / Christensen, I. J. / Nielsen, H. J. / Jensenius, J. C. / Thiel, S. et al. | 2013
- 281
-
New C1q mutation in a Tunisian familyJlejla, H. / Kallel-Sellami, M. / Imen, S. / Laadhar, L. / Zerzri, Y. / Gorgi, Y. / Makni, S. et al. | 2013
- 281
-
Defects in complement Factor H-related proteins and susceptibility to atypical Haemolytic Uraemic SyndromeBernabéu-Herrero, M. / Jiménez-Alcázar, M. / Pinto, S. / López-Trascasa, M. / de Córdoba, S. Rodríguez / Sánchez-Corral, P. et al. | 2013
- 282
-
The variant of CD11b, rs1143679, in CR3 is associated with lupus nephritis and impaired FcgR/CR cooperation in mediating the oxidative burst of neutrophilsToller-Kawahisa, J.E. / Vigato-Ferreira, I.C. / Lama, J. Cavalcanti Del / Pancoto, J. Trés / Mendes-Junior, C.T. / Martinez, E. Zangiacomi / Donadi, E.A. / Louzada-Júnior, P. / Azzolini, A.E.C. / Lucisano-Valim, Y.M. et al. | 2013
- 282
-
Expression of recombinant ARMS2 and binding to self cell surfaces via glycosaminoglycansMicklisch, S. / Schult, K. / Zipfel, P. F. / Skerka, C. et al. | 2013
- 282
-
C1 esterase inhibitor deficiency and SLE: A case report and review of the literatureBaldovino, S. / Naretto, C. / Mereuta, M. / Sciascia, S. / Manna, E. / Salussolia, I. / Strani, G. / Giancaspero, K. / Menegatti, E. / Roccatello, D. et al. | 2013
- 283
-
Improved antibody-induced cell-mediated killing (CDCC) and apoptosis of HER2 positive tumors after silencing membrane complement regulatorsMamidi, S. / Hone, S. / Kirschfink, M. et al. | 2013
- 283
-
Complement activation in vascularized composite allotransplantationGajanayake, T. / Olariu, R. / Leclere, F. / Vemula, P. / Yang, Z. / Bongoni, A. / Banz, Y. / Constantinescu, M. / Vogelin, E. / Rieben, R. et al. | 2013
- 284
-
Proteomic profiling of hepatocellular carcinoma: Elevated circulating complement C3 protein level displays role for potential early cancer biomarkerMalik, S. / Katare, D.P. / Jain, S. et al. | 2013
- 284
-
Complement gene expression pro@?ling of peripheral blood mononuclear leukocytes from patients with psoriasisLiauchenia, M. / Leonid, T. et al. | 2013
- 284
-
Complement deposition on red blood cells and red blood cell-derived microparticles during hemolytic uremic syndromeArvidsson, I. / Ståhl, A.-L. / Hedström, M. Manea / Kristoffersson, A.-C. / Westman, J. / Storry, J. / Olsson, M.L. / Karpman, D. et al. | 2013
- 285
-
Inhibition of the complement alternative pathway during cold ischemia improves survival and graft functionQi, S. / Yu, Z.- X. / Wu, Z. / Barama, A. / Xu, J. / Marozsan, A. / Wang, Y. et al. | 2013
- 285
-
Zinc-induced self-association of complement C3b and Factor H: Implications for inflammation and age-related macular degenerationNan, R. / Tetchner, S. / Rodriguez, E. / Pao, P. J. / Gor, J. / Lengyel, I. / Perkins, S. et al. | 2013
- 286
-
Renal complement deposition in a mouse model of Shiga toxin-producing E. coli infectionRebetz, J. / Bekassy, Z. / Karpman, D. et al. | 2013
- 286
-
C3 convertase antibodies in membranoproliferative glomerulonephritisLindner, S. / Chen, Q. / Kirschfink, M. / Nilsson, B. / Nilsson-Ekdahl, K. / Wolf, G. / Zipfel, P. F. et al. | 2013
- 286
-
Complement anaphylatoxin levels during exacerbations of COPD and recoveryWestwood, J.-P. / Mackay, A. / Wedzicha, W. / Machin, S. / Scully, M. et al. | 2013
- 287
-
Differential expression of CD35 and cytokines and their correlations in rheumatoid arthritis patientsAnand, D. / Kanjilal, M. / Kaur, S. / Aggarwal, H. / Kumar, U. / Das, N. et al. | 2013
- 287
-
Pentraxin-3 serum levels are associated with disease severity and mortality in patients with systemic inflammatory response syndromeBastrup-Birk, S. / Skjoedt, M. O. / Munthe-Fog, L. / Ma, Y. J. / Garred, P. et al. | 2013
- 287
-
Monoclonal antibody against factor B that inhibits formation of the AP C3 convertaseHidalgo, M. S. / Lopez, L. J. / Dominguez, M. / de Cordoba, S. R. et al. | 2013
- 288
-
Effect of low molecular weight dextran sulfate on tourniquet-induced limb ischemia/reperfusion injury and distant lung damageDührkop, C. / Rieben, R. et al. | 2013
- 288
-
Effects of C1 esterase inhibitor on distant organ damage induced by ischemia/reperfusion injury of the lower extremityDuhrkop, C. / Banz, Y. / Spirig, R. / Miescher, S. / Nolte, M. W. / Spycher, M. / Rieben, R. et al. | 2013
- 288
-
C1 esterase inhibitor protects against peripheral ischemia/reperfusion injury and distant lung damageDuhrkop, C. / Banz, Y. / Spirig, R. / Miescher, S. / Nolte, M. W. / Spycher, M. / Sacks, S. H. / Smith, R. A. G. / Rieben, R. et al. | 2013
- 289
-
Development of a recombinant antibody for the detection of activated MBLMacor, P. / Durigutto, P. / De Maso, L. / Mezzaroba, N. / Furlanis, L. / Garred, P. / Sblattero, D. / Tedesco, F. et al. | 2013
- 289
-
Comprehensive functional characterization of an engineered factor H construct combining complement regulatory and surface recognition domainsHebecker, M. / Alba-Dominguez, M. / Roumenina, L. T. / Reuter, S. / Hyvarinen, S. / Dragon-Durey, M. A. / Jokiranta, T. S. / Sanchez-Corral, P. / Jozsi, M. et al. | 2013
- 290
-
Inhibition of alternative complement pathway prevents the immediate complement activation after intraportal adult porcine islet transplantation in non-human primatesKang, H. J. / Lee, H. / Ha, J. M. / Shin, J. S. / Kim, K. Y. / Park, C. G. / Kim, S. J. et al. | 2013
- 290
-
Identification and characterization of classical complement pathway inhibitors and their application to in vivo and ex vivo disease modelsParry, G. / Panicker, S. / Byun, T. / Ramos, C. / Tom, S. / Rose, E. / Nguyen, L. / Shi, J. / Van Vlasselaer, P. / Stagliano, N. et al. | 2013
- 291
-
C1 inhibitor function with kinin forming enzymes as target: Evaluation of a novel assayGhannam, A. / Defendi, F. / Favier, B. / Ponard, D. / Drouet, C. et al. | 2013
- 291
-
Rapid diagnosis of aetiology of atypical HUS leads to early and optimal treatmentMalina, M. / Rosik, T. / Zieg, J. / Dusek, J. / Hrachovinova, I. / Seeman, T. et al. | 2013
- 291
-
The role of Properdin in the development and progression of age-related macular degenerationPauly, D. / Nagel, B.M. / Schäfer, N. / Weber, B.H.F. et al. | 2013
- 292
-
Resampling model of the complement component functional assay: Are we measuring what we think we are measuring?Pavlov, I. / Delgado, J. et al. | 2013
- 292
-
Complement-dependent cytotoxicity exerted by two therapeutic anti-CD20 mAbs: Rituximab and ofatumumab in human B-cell malignant cell lines and primary culturesOkroj, M. / Eriksson, I. / Österborg, A. / Blom, A. et al. | 2013
- 293
-
Standardisation of the factor H autoantibody assayWatson, R. / Lindner, S. / Bordereau, P. / Hunze, E. M. / Tak, F. / Ngo, S. / Zipfel, P. / Skerka, C. / Dragon-Durey, M. A. / Marchbank, K. J. et al. | 2013
- 293
-
Soluble CR1 and its potential as a therapy for C3 glomerulopathyNester, C. / Yang, Y. / Holanda, D. / Marsh, H. / Hammond, R. / Thomas, L. / Sethi, S. / Smith, R.J.H. et al. | 2013
- 293
-
Skewing of SAG mediated therapy for a predominant Th1 during Visceral Leishmaniasis on triggering CD2 epitopeSinha, S. / Bimal, S. / Sundaram, S. et al. | 2013
- 294
-
Double-blockade of CD14 and complement component C5 abolish the inflammatory storm and improve survival in mouse polymicrobial sepsisMollnes, T. / Baratt-Due, A. / Pischke, S. / Sandanger, î / Nilsson, P. / Lambris, J. / Nunn, M. / Denk, S. / Espevik, T. / Huber-Lang, M. et al. | 2013
- 294
-
Genetic polymorphisms of complement factor H in schizophrenia and ischemic strokeBoyajyan, A. / Ghazaryan, H. / Stepanyan, A. / Zakharyan, R. et al. | 2013
- 294
-
Novel C1q mutation in an homozygous C1q-deficienct patient affected of glomerulonephritis and Rothmund-Thomson SyndromeLopez-Lera, A. / Torres-Canizales, J. / Garrido, S. / Morales, A. / Lopez-Trascasa, M. et al. | 2013
- 295
-
Genetic variation of COLEC10 and COLEC11 in CaucasiansOlmos, R. B. / Garred, P. / Munthe-Fog, L. et al. | 2013
- 295
-
A high throughput automated quantitative 384 wells ELISA assay for simultaneous quantification of multiple parameters from the lectin complement pathwaySchneider, L. / Clausen, J.B. / Garred, P. / Munthe-Fog, L. et al. | 2013
- 296
-
Interferon alpha regulates the Mbl1 gene expressionDragushchenko, O. / Markadeiev, M. / Obolenskaya, M. et al. | 2013
- 296
-
A novel mutation in C5 deficiency identified by exome sequencingSchejbel, L. / Lappegaard, K.T. / Mollnes, T.E. / Garred, P. et al. | 2013
- 296
-
Characterization of a gene coding for C3 complement component from Loxosceles spider venom glandMyamoto, D. T. / de Andrade, R. M. G. / Queiroz, G. P. / Tambourgi, D. V. et al. | 2013
- 297
-
Lectin pathway inhibition by parasitic scabies mites: Molecular characterisation of host-pathogen immune mechanismsReynolds, S. / Mika, A. / Pike, R. / Blom, A. / Kemp, D. / Fischer, K. et al. | 2013
- 297
-
A novel fusion gene CHFR5–CFHR2 causes C3 GlomerulonephritisZhang, Y. / Xiao, X. / Garcia-Fernandez, J. / de Cordoba, S. Rodriquez / Zipfel, P. / Meyer, N. / Sethi, S. / Nester, C. / Ghossein, C. / Smith, R. et al. | 2013
- 298
-
Compound heterozygous mutations in the C6-gene in a child with relapsing bacterial and viral infectionsWestra, D. / Kurvers, R.A.J. / van den Heuvel, L.P. / Wurzner, R. / Kar, N.C.A. van de / Warris, A. et al. | 2013
- 298
-
The complement system genes expression by peripheral blood mononuclear cells under the S. aureus, Candida albicans and S. pyogen@?s lysates stimulation in vitroLiauchenia, M. / Titov, L. et al. | 2013
- 298
-
Epidemiological factors and food: Which is the role in helicobacter pylori re-infection in pediatric age?Sabbi, T. et al. | 2013
- 299
-
Complement defects in patients with chronic rhinosinusitisGaunsbaek, M.Q. / Lange, B. / Kjeldsen, A.D. / Svane-Knudsen, V. / Skjødt, K. / Henriksen, M.L. / Nielsen, C. / Palarasah, Y. / Hansen, S. et al. | 2013
- 299
-
The role of mannose binding lectin in infectious complications of hemato-oncologic diseasesDobi, M. / Szil gyi, I. / Csuka, D. / Varga, L. / Proh szka, Z. / Kov cs, G. / Fekete, F. et al. | 2013
- 299
-
Role of mannose binding lectin in susceptibility to tuberculosisKrusch, M. / Walter, K. / Thye, T. / Niemann, S. / Homolka, S. / Intemann, C.D. / Köhl, J. / Rüsch-Gerdes, S. / Horstmann, R.D. / Meyer, C.G. et al. | 2013
- 300
-
Complement activation has negative regulatory effects on human NK cell activation and effector functionMin, X. Y. / Liu, C. F. / Wei, Y. / Wang, N. / Li, Z. F. / Li, K. / Zhou, W. et al. | 2013
- 300
-
B-GlcNAc on Wall teichoic acids in Staphylococcus aureus triggers complement activation via lectin pathwayLi, X. et al. | 2013
- 301
-
Collectin CL-P1 is an endocytosis and phagocytosis receptor using clathrin-dependent endocytosis pathway and clathrin-independent phagocytosis pathwayWakamiya, N. / Jang, S. / Fukuoh, A. / Mori, K. / Suzuki, Y. / Ohtani, K. et al. | 2013
- 301
-
MASP-1 induces inflammatory cytokine production in monocytesParéj, K. / Sándor, N. / Dobó, J. / Závodszky, P. / Bajtay, Z. / Gál, P. et al. | 2013
- 301
-
Human serum amyloid P component is a novel peptidoglycan recognition protein inducing complement-independent phagocytosis of Staphylococcus aureusAn, J.-H. / Kurokawa, K. / Jung, D.-J. / Fujimoto, Y. / Fukase, K. / Lee, B.L. et al. | 2013
- 302
-
An interaction of H-ficolin with lipopolysaccharide contributes to aggregation, phagocytosis and killing of Hafnia alvei 1200 bacterial cellsMichalski, M. / Swierzko, A. S. / Sokolowska, A. / Lukasiewicz, J. / Man-Kupisinska, A. / Cedzynski, M. et al. | 2013
- 302
-
Complement-activating lectins in neonatal sepsisCedzynski, M. / Chojnacka, K. / Sobocinski, M. / Swierzko, A. S. / Szala, A. / Sokolowska, A. / Michalski, M. / Lukasiewicz, J. / Maciejewska, A. / Szczapa, J. et al. | 2013
- 302
-
H-ficolin (ficolin-3) concentrations and FCN3 gene polymorphism in patients with lupus nephritis and primary glomerulonephritidesUcieklak, K. / Michalski, M. / Niemir, Z. / Swierzko, A. S. / Polcyn-Adamczak, M. / Szala, A. / Lukasiewicz, J. / Cedzynski, M. et al. | 2013
- 303
-
Collectins and ficolins in Mycobacterium tuberculosis infections in Polish patientsSokolowska, A. / Swierzko, A. S. / Szala, A. / Michalski, M. / Augustynowcz-Kopec, E. / Niemiec, T. / Blachnio, M. / Dziadek, J. / Cedzynski, M. et al. | 2013
- 303
-
The interaction of complement-activating lectins with Mycobacterium tuberculosisBartlomiejczyk, M. A. / Swierzko, A. S. / Brzostek, A. / Dziadek, J. / Cedzynski, M. et al. | 2013
- 304
-
Combined inhibition of C3 and CD14 attenuates the inflammatory reaction significantly more as compared to single inhibitionEgge, K. H. / Thorgersen, E. B. / Lindstad, J. K. / Pharo, A. M. / Lambris, J. D. / Barratt-Due, A. / Mollnes, T. E. et al. | 2013
- 304
-
L- and H-ficolins in women with malignant and benign ovarian tumoursSzala, A. / Sawicki, S. / Swierzko, A. S. / Szemraj, J. / Marcin, S. / Michalski, M. / Kaluzynski, A. / Lukasiewicz, J. / Maciejewska, A. / Wydra, D. et al. | 2013
- 304
-
Mitochondria and the lectin pathway of complementBrinkmann, C. / Jensen, L. / Dagnaes-Hansen, F. / Holm, I. / Endo, Y. / Fujita, T. / Thiel, S. / Jensenius, J. / Degn, S. et al. | 2013
- 305
-
Three-dimensional quantitative structure-activity relationship and docking studies on a series of anthocyanin derivatives as cytochrome P450 3A4 inhibitorsShityakov, S. / Broscheit, J. / Roewer, N. / Forster, C. et al. | 2013
- 305
-
IgG4-related disease with normal complement factors: A case presentationWindisch, C. / Grone, H. J. / Ruster, C. / Oelzner, P. / Neumann, T. / Wolf, G. et al. | 2013
- 305
-
Detection of FH concentration in children with hematuriaSavic, O. / Jaglicic, I. et al. | 2013
- 306
-
Characterization of the interaction between Collectin 11 (CL-11, CL-K1) and nucleic acidsHenriksen, M.L. / Brandt, J. / Iyer, S.S.C. / Thielens, N.M. / Hansen, S. et al. | 2013
- 306
-
Study of early immunological responses during ex vivo xenoperfusion of (hCD46 and HLA-E)-double transgenic porcine limbs with whole, heparin anti-coagulated human bloodBongoni, A. K. / Keirmeir, D. / Constantinescu, M. A. / Jenni, H. / Bahr, A. / Ayares, D. / Vogelin, E. / Klymiuk, N. / Seebach, J. / Rieben, R. et al. | 2013
- 307
-
Complement-related factors, synaptic activity and schizophrenia – Is there a link?Haavik, B. et al. | 2013
- 307
-
Prediction of hypersensitivity reactions to anticancer drugs and monoclonal antibodies by testing complement activation in vitroSzebeni, J. / Meszaros, T. / Weiszhar, Z. / Schneider, T. / Rosivall, L. / Rosta, A. / Urbanics, R. et al. | 2013
- 307
-
Recombinant expression of the autocatalytic complement protease MASP-1 is crucially dependent on co-expression with its inhibitor, C1 inhibitorDegn, S. / Thiel, S. / Jensenius, J. et al. | 2013
- 308
-
C1-inhibitor functional activity is impaired upon complex formation with amyloid beta (Aβ)Veerhuis, R. / Koel-Simmelink, M.J.A. et al. | 2013
- 308
-
The choline-binding protein PspC of Streptococcus pneumoniae interacts with the C-terminal heparin-binding domain of vitronectinHallstrom, T. / Voss, S. / Singh, B. / Riesbeck, K. / Hammerschmidt, S. / Zipfel, P. F. et al. | 2013
- 308
-
C1-inhibitor functional activity is impaired upon complex formation with amyloid beta (A@b)Veerhuis, R. / Koel-Simmelink, M. J. A. et al. | 2013
- 309
-
Isolation and identification of Legionella pneumophila from environmental water sources in Khartoum StateMohamed, M. O. et al. | 2013
- 309
-
The ratio between C4 and C4BP adsorbed to artificial materials is a new predictor for biocompatibilityEngberg, A. E. / Nilsson, P. H. / Sandholm, K. / Huang, S. / Mollnes, T. E. / Nicholls, I. A. / Nilsson, B. / Ekdahl, K. N. et al. | 2013
- 310
-
A case of hemolytic uremic syndrome associated with a post-infectious glomerulonephritis: A major pathophysiological role of complement activation?Davin, J.-C. / Groothoff, J.W. / Oosterveld, M. / Schriemer, R. / van de Kar, N. / Varnarmkhasti, M. Tebbe / Bouts, A. / Florquin, S. et al. | 2013
- 310
-
Keiner angegebenChiodini, B.D. / Davin, J.-C. / Corazza, F. / Khaldi, K. / Dahan, K. / Lolin, K. / Ismaili, K. / Adams, B. et al. | 2013
- 311
-
Staphylococcus aureus Panton-Valentine-Leukocidin causes neutrophil destruction resulting in activation of platelets which can be inhibited by plasma antibodies against leukocidinsNiemann, S. / Bertling, A. / Kehrel, B.E. / Peters, G. / Löffler, B. et al. | 2013
- 311
-
A metalloproteinase mirolysin of Tannerella forsythia inhibits all pathways of the complement systemJusko, M. / Potempa, J. / Ksiazek, M. / Riesbeck, K. / Garred, P. / Eick, S. / Blom, A.M. et al. | 2013
- 311
-
Pathogenic Leptospira evades human complement attack by the secretion of metalloproteasesFraga, T. R. / Courrol, D. D. S. / Castiblanco-Valencia, M. / Hirata, I. / Juliano, L. / Vasconcellos, S. / Barbosa, A. S. / Isaac, L. et al. | 2013
- 312
-
Investigating how the highly virulent Streptococcus pyogenes AP1 strain binds and interacts with human C4BP to evade complement attackErmert, D. / Weckel, A. / Frick, I. M. / Bjorck, L. / Blom, A. et al. | 2013
- 312
-
The role of soluble complement receptor type 2 (CR2/CD21) in immune evasion of Candida albicansBuhlmann, D. / Eberhardt, H.U. / Prodinger, W.M. / Skerka, C. et al. | 2013
- 312
-
Elongation Factor Tu (Tuf) is a new virulence factor of Streptococcus pneumoniae that binds human complement factors, aids in immune evasion and host tissue invasionSarkar, S. / Hallstrom, T. / Hammerschmidt, S. / Skerka, C. / Zipfel, P. F. et al. | 2013
- 313
-
Binding of recombinant factor H-related proteins to meningococcal factor H-binding proteinPouw, R. B. / Brouwer, M. C. / Tang, C. M. / Wouters, D. / Kuijpers, T. W. et al. | 2013
- 313
-
Secreted aspartic protease 2 of Candida albicans cleaves factor H and the macrophage factor H-receptorsSvobodová, E. / Staib, P. / Kremlitzka, M. / Barz, D. / Józsi, M. et al. | 2013
- 314
-
Sequence variations and expression of the Candida albicans immune evasion proteins Gpm1 and Pra1 in clinical isolates contribute to virulenceLuo, S. / Hipler, U.-C. / Münzberg, C. / Skerka, C. / Verschoor, A. / Zipfel, P.F. et al. | 2013
- 314
-
Genetic manipulation of the relapsing fever spirochete Borrelia hermsii permits study of the role of factor H binding and a novel complement evasion mechanismMiller, D. P. / Fine, L. / Marconi, R. T. et al. | 2013
- 314
-
Pra1 from Candida albicans has a metalloprotease function to cleave the central complement component C3Pilz, C. / Luo, S. / Hartmann, A. / Skerka, C. / Zipfel, P. F. et al. | 2013
- 315
-
Study of interleukin 12-gamma interferon axis and natural killer cells in acute viral hepatitisEl Sayed Zaki, M. / Magdy Abdel Razek, M. et al. | 2013
- 315
-
Characterization of plasminogen binding to factor H binding protein (FhbB) of the periopathogen Treponema denticolaTegels, B. / Miller, D. / Marconi, R. et al. | 2013
- 315
-
Survival of S. aureus in blood can be impaired with factor H fragment FH5–7Haapasalo-Tuomainen, K. / Kirveskari, J. / Kuusela, P. / Jokiranta, S. et al. | 2013
- 316
-
Structural studies on human complement component C4Sirotkina, S. / Andersen, G. R. et al. | 2013
- 316
-
Characterization of the bactericidal activity of mammalian serum on S. aureusGonzalez M., B. et al. | 2013
-
Editorial Board/Publication Information| 2013